Showing results (2871-2880 of 2,923) with videos related to

Sort By:
Pageof 293
Bioorganic & Medicinal Chemistry|July 21, 2022
Synthesis and biological evaluation of 4-(4-aminophenyl)-6-methylisoxazolo[3,4-b] pyridin-3-amine covalent inhibitors as potential agents for the treatment of acute myeloid leukemiaJi-Bo Kang, Lu Chen, Xue-Jiao Leng, et al.
Journal of Medicinal Chemistry|December 26, 2024
Design, Synthesis, and Biological Evaluation of 3,4-Dihydroisoquinolin-1(2H)-one Derivatives as Protein Arginine Methyltransferase 5 Inhibitors for the Treatment of Non-Hodgkin's LymphomaQing-Qing Li, Xu Quan, Zi-Xuan Wang, et al.
Gerontology|February 2, 2016
Impact of Alzheimer's Disease in Nine Asian CountriesYuan-Han Yang, Kenichi Meguro, Sang-Yun Kim, et al.
The European Respiratory Journal|April 27, 2023
Nicotine promotes e-cigarette vapour-induced lung inflammation and structural alterationsElsa T Roxlau, Oleg Pak, Stefan Hadzic, et al.
Leukemia|November 9, 2022
Inhibition of USP1 reverses the chemotherapy resistance through destabilization of MAX in the relapsed/refractory B-cell lymphomaXi-Ya Li, Ji-Chuan Wu, Ping Liu, et al.
Scientific Reports|March 26, 2025
Preoperative ECOG performance status as a predictor of outcomes in upper tract urothelial cancer surgeryTsung-Mu Yang, I-Hsuan Alan Chen, Chia-Cheng Yu, et al.
Journal of the American Medical Directors Association|July 6, 2017
Attitudes Toward Advance Directives Among Patients and Their Family Members in ChinaLin Kang, Xiao-Hong Liu, Jing Zhang, et al.
Journal of Neurosurgery|October 24, 2025
Adjunct percutaneous transluminal angioplasty and stenting in endovascular thrombectomy with underlying intracranial stenosis: analysis of the TREAT-AIS registryYen-Heng Lin, Chih-Hao Chen, Yi-Chen Hsieh, et al.
Advanced Materials (Deerfield Beach, Fla.)|December 20, 2024
A Library of Seed@High-Entropy-Alloy Core-shell Nanocrystals With Controlled Facets for CatalysisYueh-Chun Hsiao, Cheng-Yu Wu, Chih-Heng Lee, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 24, 2023
Preclinical characterization of danatinib as a novel FLT3 inhibitor with excellent efficacy against resistant acute myeloid leukemiaShan-Liang Sun, Jia-Zhen Wu, Jing-Jing Wang, et al.
Pageof 293